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Summary 
 
N-Linked glycosylation a common type of glycosidic bond. It is thought to be important for 
folding, stability, and vast degree of biological functions of glycoproteins. These different 
effects on glycoproteins mainly result from the different N-linked glycan structures determined 
by various glycosyltransferases. Among these, α1,6-fucosyltransferase (Fut8) is the only 
enzyme that catalyzes the transfer of a fucose from GDP-fucose to the innermost GlcNAc 
residue via α1,6-linkage to form core fucosylation in mammals. The enzymatic products, core 
fucosylated N-glycans, are widely distributed in a variety of glycoproteins and have been 
shown to play important roles in cell signaling. As examples, we previously showed that core 
fucosylation is crucial for the ligand binding affinity of transforming growth factor (TGF)-β1 
receptor, epidermal growth factor (EGF) receptor, and integrin α3β1. Lacking the core fucose 
of these receptors led to a marked reduction in their ligand-binding ability and downstream 
signaling. Recently, our group found that a loss of core fucose on activin receptors resulted in 
an enhancement of the formation of activin receptor complexes, which constitutively activated 
intracellular signaling. These studies indicate that core fucosylation is able to negatively or 
positively affect signaling pathways through regulation of receptor binding ability, which could 
be important for appropriate signaling in vivo.  
 
Part 1: Loss of α1,6-fucosyltransferase suppressed liver regeneration: implication of core 
fucose in the regulation of growth factor receptor-mediated cellular signaling 
Liver regeneration after partial hepatectomy (PH) is a complicated process. At the cellular level, 
it proceeds with the coordinated proliferation of all types of mature hepatic cells. Among these, 
it has been generally accepted that the restoration of liver volume depends mainly on the 
proliferation of hepatocytes. Molecularly, PH triggers multiple intracellular signaling cascades 
(RAS/mitogen-activated protein kinase (MAPK) signaling, c-Met signaling, etc), leading to 
great changes in the expression of genes associated with cell proliferation. The convergence of 
these signaling pathways has been reportedly mediated via EGFR and hepatocyte growth factor 
receptor (c-Met). Blocking the EGFR- or c-Met-mediated signaling pathway could cause a 
severe delay of liver regeneration in mice. In addition to the expression level of EGFR and 
c-Met proteins, it has been shown that the post-translational modification of these receptors 
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such as ubiquitination, phosphorylation, and glycosylation also plays a crucial role in the 
regulation of these signaling pathways.  
Recently it was reported that core fucosylation on some glycoproteins, such as vitronectin, 
increased during liver regeneration after PH. However, the underlying mechanisms remain 
poorly understood. Here, we investigated the role of Fut8 in liver regeneration and showed for 
the first time that core fucosylation is physiologically associated with the liver regeneration. 
Firstly, we detected the enzyme activities of Fut8 in the liver tissues at different time points 
after 70% PH. The Fut8 activities were increased in the first 4 days after operation, and 
returned to normal levels after liver mass is restored. These data indicated that the induction of 
Fut8 expression might be required for liver regeneration. To testify the hypothesis above, we 
performed a 70% PH on both Fut8+/+ and Fut8-/- mice, and analyzed the restoration of their 
livers. Interestingly, the regeneration index calculated as an increase in liver-to-body weight 
ratio was significantly lower in Fut8-/- mice than that in Fut8+/+ mice. Furthermore, a decrease 
in liver regeneration was also observed in the Fut8+/- mice during the first 2 days.  
Liver regeneration was achieved by the coordinated proliferation of all types of mature hepatic 
cells. Consistent with the results above, quantitative assessment of Ki67 by immunostaining 
revealed little difference between Fut8-/- and Fut8+/+ mice without PH, while, the percentage of 
Ki67 positive versus TO-PRO-3 iodide positive cells in the livers of Fut8-/- mice were 
markedly less than that in Fut8+/+ mice at day 2 after PH. These differences in cell proliferation 
were further reflected by the cell proliferation signaling. Overall, these data indicated that the 
delayed liver recovery in Fut8-/- mice resulted from the lower cell proliferation.  
It is known that two pathways for the synthesis of GDP-fucose in mammalian cells, the 
GDP-mannose-dependent de novo pathway and the free fucose-dependent salvage pathway. 
And what is more, administration of oral L-fucose, an enhancement of the salvage pathway, 
has been proven useful for correction of fucosylation defects in leukocyte adhesion deficiency 
type II patients. To determine whether enhancing GDP-fucose salvage pathway could 
complement the delayed liver regeneration of the Fut8+/- mice as described above, we checked 
the effects of L-fucose supplementation in the Fut8+/- mice. Interestingly, an oral administration 
of L-fucose significantly accelerated liver regeneration of the Fut8+/- mice, but did not affect 
sham mice. Consistently, in contrast to the little difference in the case of livers without 70% PH, 
immunostaining with Ki67 showed the ratio of Ki67+ to TO-PRO-3 iodide+ cells in the livers 
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treated by PH were clearly increased after L-fucose administration. These results further 
suggest that Fut8 and its products are important for cell proliferation in liver regeneration. 
The EGFR ligands and HGF are major mitogens for hepatocytes in the regenerating liver. 
Lacking EGFR or c-Met in mice resulted in the liver regeneration abnormalities. To determine 
whether the delayed liver recovery in the Fut8-/- mice is due to the impaired EGFR and/or 
c-Met signaling, we tested the expression levels of the key effectors in these signaling 
pathways. Although c-Met and EGFR associated signaling pathways were activated in both 
Fut8+/+ and Fut8-/- mice 2 days post PH, the levels of phosphorylated c-Met and EGFR in 
Fut8-/- mice were obviously lower than that in Fut8+/+ mice. These results indicated that loss of 
Fut8 impaired EGFR and c-Met associated signaling during liver regeneration. 
To further corroborate the results above in vitro, we examined the downstream signaling 
cascades of EGF or HGF using the primary hepatocytes isolated from Fut8+/+ and Fut8-/- mice. 
Consistently, the treatments with EGF or HGF significantly increased the expression levels of 
phosphorylated ERK and AKT in the Fut8+/+ cells. However, these increases were greatly 
suppressed in the Fut8-/- cells. The results above clearly demonstrated that the impaired 
regeneration in Fut8-/- livers was due, at least mainly, to the down-regulated EGFR- and 
c-Met-mediated signaling in hepatocytes. 
Overall, this study marks the first clear demonstration of the biological functions of Fut8 in the 
liver, suggesting that core fucosylation plays important roles in liver regenerating progression. 
 
Part 2. Loss of α1,6-fucosyltransferase inhibits chemical induced hepatocellular 
carcinoma and tumorigenesis by down-regulating several cell signaling pathways 
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality 
worldwide, and hepatocarcinogenesis is a complicated process associated with the 
accumulation of pathological changes during the initiation, promotion, and progression of the 
disease. Identifying these changes may provide an avenue to develop a new generation of 
potential biomarkers, as well as therapeutic targets for HCC. It has been shown that altered 
expressions of growth factors such as EGF, TGF-α, TGF-β, and HGF, as well as their receptors 
during the development of HCC, influence the survival of cancerous cells by suppressing 
apoptosis and regulating the cell cycle.  
It has been reported that the up-regulation of core fucosylation catalyzed by Fut8 has been 
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observed in pathological conditions such as HCC, and the fucosylated AFP (AFP-L3) is a 
reliable marker that can be used to distinguish patients with HCC from those with chronic 
hepatitis and liver cirrhosis. The HCC cases with high Fut8 expression is associated with the 
poor prognosis. These information prompted us to wonder what the pathological role of high 
Fut8 expression is in HCC progression and whether it could serve as a potential therapeutic 
target for liver cancer. 
To explore the effects of high Fut8 expression and their molecular mechanisms in 
hepatocarcinogensis, here, the male wild-type (Fut8+/+), hetero (Fut8+/-) and knockout (Fut8-/-) 
mice were used to establish the chemical induced HCC models by diethylnitrosamine (DEN) 
and pentobarbital (PB). The induction of HCC was significantly suppressed in Fut8-/- mice, 
meanwhile, the expression of Fut8 was greatly increased in the liver tissues of Fut8+/+ mice 
during the process. Consistently, liver functions were destroyed in the Fut8+/+ mice and Fut8+/- 
mice, but not Fut8-/- mice.  
DEN exerts carcinogenicity after being bioactivated by cytochrome P450 (CYP) enzymes in 
the liver. To check the early effects of DEN in Fut8+/+ and Fut8-/- mice, semi-quantitative or 
quantitative PCR analysis of mRNAs encoding the CYP enzyme and Mgmt genes was 
performed at 2 h after DEN injection. There was no significant difference in the transcriptional 
levels of either CYP genes or DNA repair gene between Fut8+/+ and Fut8-/- mice. DEN-induced 
tumor formation was further associated with substantial and marked induction of 
proinflammatory chemokines within the livers of mice. Quantitative PCR analysis of livers 
after DEN injection revealed increase in IL-6 and TNFα expression levels in both Fut8+/+ and 
Fut8-/- mice, but there was no significant difference between the Fut8+/+ and Fut8-/- mice. 
Moreover, TUNEL assay for the livers showed the similar results. These data demonstrate that 
the expression of Fut8 may not affect the acute phase response to DEN. 
Cell proliferation plays important roles in HCC process. In order to find the possible 
mechanisms for the differences in tumorigenesis described above, we carried out Ki67 
immunostaining for the frozen liver tissues of Fut8+/+ and Fut8-/- mice. After chemical 
induction, the Fut8+/+ mice showed a significant increase by more than ~6.5-fold in positive 
immunostaining as compared with the untreated control. However, only a 2-fold increase was 
observed in Fut8-/- mice. The expression levels of cyclin mRNAs, including Cyclin B1, Cyclin 
D1 and Cyclin E2, were also up-regulated in Fut8+/+ mice after DEN/PB treatment, and the 
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elevations in gene expression were attenuated by the ablation of Fut8. These results indicate 
that Fut8 may influence the progress of DEN/PB induced HCC by affecting the cell 
proliferation. 
The effects of Fut8 expression on tumorigenesis were further confirmed by xenograft tumors 
formed by HepG2 cells in NOD/SCID mice. Knockout of Fut8 gene in the cells completely 
inhibited tumor formation. The HepG2 cell line was also used to reveal possible mechanisms 
of Fut8 for the regulatory roles. The responses to EGF and HGF were attenuated in the Fut8 
knockout cells, although the expression levels of their receptors on the cell surface were similar. 
Considering also our previously reported that core fucosylation was required for the binding of 
the EGF to EGFR, it is reasonable to conclude that lacking the core fucosylation on both 
receptors may decrease their biological functions in vitro or in vivo. 
Taken together, it could be postulated that a loss of the Fut8 gene may affect the biological 
functions of some target membrane proteins and their subsequent downstream signaling, 
thereby inhibiting the hepatocarcinogenesis. These results suggest that the levels of core 
fucosylation are not only biomarkers, but also functional modulators in the liver. Thus, Fut8 
might be a novel therapeutic target for HCC. 
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1.1 Introduction 
 
The adult liver has a remarkable capacity to regenerate, which makes it possible to use partial 
livers from living donors for transplantation. However, certain hepatic conditions, including 
cirrhosis, steatosis, and conditions due to old age, also have impaired liver regeneration that 
results in increased morbidity and mortality in response to liver transplantation (1). Therefore, 
in the past decade, numerous studies have been focused on dissecting the molecular 
mechanisms underlying liver regeneration.   
Seventy percent partial hepatectomy (PH) is the most common technique that is used to study 
the regeneration of liver. Namely, it describes a surgical procedure which removes 70% of liver 
mass in rodents (rats and mice). Due to the multi-lobed structure of the rodent liver, three of the 
five liver lobes (representing 70% of its liver mass) can be removed. The residual lobes enlarge 
and reconstitute the original size of the liver within 2 weeks (2, 3). Regeneration after PH is a 
complicated process. At the cellular level, it proceeds with the coordinated proliferation of all 
types of mature hepatic cells. Among these, it has been generally accepted that the restoration 
of liver volume depends mainly on the proliferation of hepatocytes (4). This is not only 
because hepatocytes account for about 80% of liver weight and 70% of all liver cells, but also 
they are the first cells to enter into DNA synthesis and produce mitogenic signals for other 
hepatic cells (4, 5). Molecularly, PH triggers multiple intracellular signaling cascades 
(RAS/mitogen-activated protein kinase (MAPK) signaling, c-Met signaling, etc), leading to 
great changes in the expression of genes associated with cell proliferation (1, 6). The 
convergence of these signaling pathways has been reportedly mediated via epidermal growth 
factor receptor (EGFR) and hepatocyte growth factor receptor (c-Met) (4). Blocking the 
EGFR- or c-Met-mediated signaling pathway could cause a severe delay of liver regeneration. 
In addition to the expression level of EGFR and c-Met proteins, it has been shown that the 
post-translational modification of these receptors such as ubiquitination, phosphorylation, and 
glycosylation also plays a crucial role in the regulation of these signaling pathways (7, 8).  
Fucosylation is one type of glycosylation. It describes the attachment of a fucose residue to 
N-glycans, O-glycans, and glycolipid catalyzed by a family of enzymes called 
fucosyltransferases (Futs) (9). Among these, α1,6-fucosyltransferase (Fut8) is the only enzyme 
that catalyzes the transfer of a fucose from GDP-fucose to the innermost GlcNAc residue via 
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α1,6-linkage to form core fucosylation in mammals as shown in Figure 1c. The enzymatic 
products, core fucosylated N-glycans, are widely distributed in a variety of glycoproteins and 
have been shown to play important roles in cell signaling. As examples, we previously showed 
that core fucosylation is crucial for the ligand binding affinity of TGF-β1 receptor (10), EGF 
receptor (11), and integrin α3β1 (12). Lacking the core fucose of these receptors led to a 
marked reduction in their ligand-binding ability and downstream signaling. Recently, our group 
found that a loss of core fucose on activin receptors resulted in an enhancement of the 
formation of activin receptor complexes, which constitutively activated intracellular signaling 
(13). These studies indicate that core fucosylation is able to negatively or positively affect 
signaling pathways through regulation of receptor binding ability.  
Abnormal expression of Fut8 has been pathologically correlated with diverse carcinomas 
including liver (14), ovarian (15), lung (16) and colorectal cancers (17). Recently it was 
reported that core fucosylation on some glycoproteins, such as vitronectin, increased during 
liver regeneration after PH (18). However, the underlying mechanisms remain poorly 
understood. Here, we investigated the role of Fut8 in liver regeneration and showed for the first 
time that core fucosylation is physiologically associated with the liver regeneration. In 
particular, we show that the liver regeneration was significantly inhibited in Fut8 deficient 
(Fut8-/-) and Fut8 hetero (Fut8+/-) mice as compared to wild type (Fut8+/+) mice. It is intriguing 
that this effect could be attenuated by L-fucose supplementation in the Fut8+/- mice. Moreover, 
intracellular signaling analysis using primary hepatocytes isolated from Fut8+/+ and Fut8-/- mice 
clearly demonstrated that Fut8 is important for the initiation of hepatocyte proliferation. Taken 
together, our data here provide novel insight for the function of core fucosylation in liver 
regeneration.  
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1.2 Materials and Methods 
 
1.2.1 Mice  
The Fut8-deficient mice line used for these studies has been described previously (10, 19). 
Male mice on an ICR background at 6 to 8 weeks of age were used for the experiments in the 
present study, comparing Fut8-/- animals with Fut8+/+ littermates. Mice were housed in a 
temperature-controlled room with a 12-h dark/12-h light cycle. Food and water were provided 
ad libitum. The present study was approved by the Institutional Animal Care and Use 
Committee of Tohoku Pharmaceutical University, Japan. 
 
1.2.2 70% partial hepatectomy  
All experiments were carried out in accordance with relevant guidelines and regulations. For 
liver regeneration studies, 7- to 8- week-old mice were anesthetized with pentobarbital sodium 
and subjected to mid-ventral laparotomy with a two-third liver resection, as previously 
described (20, 21). The left and median liver lobes were surgically resected without injuring 
the remaining liver tissue. The removed parts represented the resting liver. At least three mice 
from each group were euthanized at each analysis time point. For L-fucose (Nacalai tesque Inc.) 
supplementation, 6-week-Fut8+/- mice were orally administrated with L-fucose (4 g/L in water) 
for 12 days prior to partial hepatectomy (PH), and then the livers were harvested at 48h after 
operation.    
 
1.2.3 Immunostainings 
The hepatic lobules were assessed based on 10 m frozen sections. Proliferative cells in the 
liver were detected through immunostaining with a monoclonal antibody recognizing Ki67 
(Abcam), and examined with Olympus confocal laser scanning microscope (Olympus). 
 
1.2.4 Cell culture  
Primary hepatocytes of 8-week old mice were isolated using the standard method of in situ 
collagenase (Gibco) perfusion and digestion of liver with low-speed centrifugation (50×g, 1 
min), as previously reported (22, 23). Isolated cells were plated on collagen type I-coated 
dishes in Dulbecco’s modified Eagle’s medium (DMEM) with 10% (v/v) fetal bovine serum 
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(FBS), 100 IU/mL penicillin, and 100 g/ml streptomycin. Hepatocytes were incubated for 6 h 
at 37 ˚C in a humidified atmosphere with 95% air and 5% CO2, allowing for cell attachment to 
the plate. The medium was then changed, which involved replacement by 0.1% FBS contained 
DMEM with or without EGF or HGF for stimulation at indicated times.  
 
1.2.5 Western blotting analyses 
Total protein was isolated from frozen liver tissue and cultured cells with TBS (20 mM Tris, 
150 mM NaCl, PH 7.4) containing 1% triton X-100. Protein concentration was measured using 
a bicinchoninic acid protein assay kit (Thermo Scientific). Equal protein samples were 
separated by SDS-PAGE and then transferred onto nitrocellulose or polyvinylidinedifluoride 
(Millipore) membranes. After blocking with 5% skim milk, the membranes were incubated 
with specific antibodies against the indicated antibodies at 4 ˚C overnight, followed by 
incubation with horseradish peroxidase-conjugated secondary antibody. Immunoreactivity was 
visualized by HRP substrate peroxide solution (Millipore). The related antibodies that are used 
included ERK1 (BD), phospho-ERK, phospho-AKT, AKT, phospho-Met (Tyr1234/5), c-Met, 
phospho-EGFR (Tyr1068), EGFR, rabbit IgG (Cell Signaling) and mouse IgG (Sigma). 
 
1.2.6 Enzyme activity assays for Fut8 
Frozen liver tissues were homogenized in TBS containing 1% protease inhibitor cocktail 
(Nacalai tesque Inc.). After centrifugation at 900 g for 10 min, the supernatant was collected 
for enzyme activity assays. Each sample containing 800 g of total protein was centrifuged at 
105,000 g for 1 h, then the pellet was resuspended in 0.1 M MES-NaOH (PH 7.0) for reactions. 
Equal amounts of protein were used in Fut8 activity assays. The specific activities of Fut8 were 
determined using a substrate, 4-(2-pyridylamino)-butylamine (PABA)-labeled 
GlcNAcβ1-2Manα1-6(GlcNAcβ1-2Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAc-Asn 
(GnGn-Asn-PABA). Each assay used 2 mM of acceptor substrate and 2 mM GDP-L-fucose as 
a donor (in 10 l of total reaction solution). The reactions were terminated by boiling after 2h 
of incubation at 37 ˚C, and the reaction mixtures were centrifuged at 10,000 g for 10 min. The 
result supernatants were applied to high-performance liquid chromatography (HPLC) equipped 
with a TSK-gel, ODS-80TM column (4.6×150mm) in order to separate and quantitate the 
products. Elution was performed isocratically at 55 ˚C using a 20 mM acetate buffer (pH 4.0) 
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containing 0.15% butanol. The column eluate was monitored for fluorescence using a detector 
operating at excitation and emission wavelengths of 320 and 400 nm, respectively. The 
activities of endogenous Fut8 were measured by HPLC, expressed as the pmol of fucose 
transferred/h/mg of proteins (24). 
 
1.2.7 Statistical analysis 
Results are given as the mean ± standard error of the mean (SEM). The data were analyzed 
using Prism 5.0 software (GraphPad Software Inc.). Comparisons were carried out using 
2-tailed Mann-Whitney tests and/or a Tukey’s Multiple Comparison test. A P value of less than 
0.05 was considered significant. 
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1.3 Results 
 
1.3.1 70% PH induced the expression of Fut8  
It has been reported that lacking N-acetylglucosaminyltransferase III suppressed the liver 
tumor progression and liver regeneration in mice, indicating the importance of glycosylation in 
liver (25). In the present study, we investigated the roles of Fut8 in liver regeneration. Firstly, 
we detected the enzyme activities of Fut8 in the liver tissues at different time points after 70% 
PH. As shown in Figure 1a and 1b, the Fut8 activities were increased in the first 4 days after 
operation, and returned to normal levels after liver mass is restored. On the other hand, the 
expression levels of L-fucosidase after PH were not changed confirmed by RT-PCR (data not 
shown). These data indicated that the induction of Fut8 expression might be required for liver 
regeneration. 
Figure1. The activities of Fut8 were increased after 70% partial hepatectomy (PH).  
The liver tissues were harvested for the determination of enzyme activities at indicated times as described in 
“Methods”. (a) A representative elution pattern on HPLC for Fut8 activities in Fut8+/+ mouse with (lower 
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panel) or without (upper panel) PH. S: substrate; P: product. (b) The quantitative assay for enzyme activities 
in Fut8+/+ mice after PH. *, P<0.05, compared to the group without PH (sham), which was set as 1, n=3. (c) 
Reaction for synthesis of α1,6-fucose. 
 
1.3.2 Loss of Fut8 inhibited recovery of liver mass after a two-third liver resection  
To testify the hypothesis above, we performed a 70% PH on both Fut8+/+ and Fut8-/- mice, and 
analyzed the restoration of their livers. Interestingly, the regeneration index calculated as an 
increase in liver-to-body weight ratio was significantly lower in Fut8-/- mice than that in Fut8+/+ 
mice (Figure 2a). Furthermore, a decrease in liver regeneration was also observed in the Fut8+/- 
mice during the first 2 days (Figure 2b). The results above indicated that the liver regeneration 
was inhibited in Fut8-/- mice as compared to Fut8+/+ mice.  
 
Figure 2.  Fut8 expression was required for 
liver regeneration after PH.  
7- to 8-week-old mice were surgically resected as 
described in “Methods”, and then the livers were 
harvested at the indicated times. (a) Relative liver 
weight (liver vs whole body) at the indicated 
times after 70% PH. The sham group was set as 
100%. Each set of the reported data was obtained 
from at least 5 individuals of Fut8+/+ and Fut8−/− 
mice.  *, P<0.05; **, P<0.01. (b) Comparison of 
relative weight at 2 days after PH between Fut8+/+ 
and Fut8+/- mice (C57BL/6 genetic background). 
Each data was obtained from at least 8 individuals. 
*, P<0.05, compared with the Fut8+/+ mice.  
 
Liver regeneration was achieved by the coordinated proliferation of all types of mature hepatic 
cells (2). Consistent with the results above, quantitative assessment of Ki67 by immunostaining 
revealed little difference between Fut8-/- and Fut8+/+ mice without PH, while, the percentage of 
Ki67 positive versus TO-PRO-3 iodide positive cells in the livers of Fut8-/- mice were 
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markedly less than that in Fut8+/+ mice at day 2 after PH (Figure 3a and 3b). These differences 
in cell proliferation were further reflected by the cell proliferation signaling. As shown in 
figure 3c, the phosphorylation levels of ERK were remarkably lower in the Fut8-/- mice as 
compared with Fut8+/+ mice, although the MAPK signaling pathways were activated by PH in 
both Fut8+/+ and Fut8-/- mice. Overall, these data indicated that the delayed liver recovery in 
Fut8-/- mice resulted from the lower cell proliferation.  
Figure 3. Cell proliferation was suppressed in the livers of Fut8−/− mice.  
(a) Immunostaining for liver tissues (10 m frozen section) of Fut8+/+ and Fut8−/− mice using anti-Ki67 
antibody (200×field). The positive cells of the immunostaining were labeled with the green spots (left panel), 
and the nuclei were labeled by TO-PRO-3 iodide (red spots, middle panel). (b) The quantitative data were 
obtained from at least 3 mice in each group. **, P<0.01. (c) Equal protein of liver lysates at day 2 after PH 
were separated by 10% SDS-PAGE and blotted with anti-phospho-ERK and anti-ERK1 antibodies. The 
quantitative data were obtained from 3 mice in each group. *, P<0.05, **, P<0.01.  
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1.3.3 L-fucose administration in Fut8+/- mice attenuated the inhibitory effect in cell 
proliferation as described above. 
GDP-fucose is the donor for fucosyltransferases. It is known that two pathways for the 
synthesis of GDP-fucose in mammalian cells, the GDP-mannose-dependent de novo pathway 
and the free fucose-dependent salvage pathway (26). And what is more, administration of oral 
L-fucose, an enhancement of the salvage pathway, has been proven useful for correction of 
fucosylation defects in leukocyte adhesion deficiency type II (LAD II) patients (27). To 
determine whether enhancing GDP-fucose salvage pathway could complement the delayed 
liver regeneration of the Fut8+/- mice as described above, we checked the effects of L-fucose 
supplementation in the Fut8+/- mice. Interestingly, an oral administration of L-fucose 
significantly accelerated liver regeneration of the Fut8+/- mice, but did not affect sham mice 
(Figure 4a). Consistently, in contrast to the little difference in the case of livers without 70% 
PH, immunostaining with Ki67 showed the ratio of Ki67+ to TO-PRO-3 iodide+ cells in the 
livers treated by PH were clearly increased after L-fucose administration (Figure 4b and 4c). 
Moreover, as shown in figure 4d and 4e, the phosphorylation levels of ERK and EGFR were 
induced in Fut8+/- mice after PH. Furthermore, the L-fucose administration up-regulated their 
phosphorylation levels, although there was no significant difference between the mice treated 
with or without L-fucose by statistical analysis. These results further suggest that Fut8 and its 
products are important for cell proliferation in liver regeneration. 
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Figure 4. L-fucose supplementation attenuated the decreased regeneration of Fut8+/- mice.  
(a) Relative liver weight (liver vs whole body) at 2-day after PH in Fut8+/- mice with or without 
administration of L-fucose. Prior to operation, 6-week old Fut8+/- mice were administrated with L-fucose at 
4g/L in water for 12 days, and then the livers were harvested at 48 hours after PH.  The sham group without 
L-fucose treatment was set as 100%. *, P<0.05, compared with the mice without L-fucose treatment (n >10 
mice). (b) Immunostaining for liver tissues using anti-Ki67 antibody (200×field). (c) The quantitative data 
were obtained from at least 3 mice in each group, *, P<0.05. (d and e) Equal protein of liver lysates at day 2 
after PH were separated by SDS-PAGE (10% for pERK/ERK1, 7% for pEGFR/EGFR) and blotted with 
anti-phospho-ERK and anti-ERK1 antibodies. The quantitative data were obtained from 3 mice in each 
group. 
 
1.3.4 The intracellular signaling was inhibited in the Fut8-/- primary hepatocytes upon 
stimulation with EGF or HGF 
The EGFR ligands and HGF are major mitogens for hepatocytes in the regenerating liver. 
Lacking EGFR or c-Met in mice resulted in the liver regeneration abnormalities (28, 29). To 
determine whether the delayed liver recovery in the Fut8-/- mice is due to the impaired EGFR 
and/or c-Met signaling, we tested the expression levels of the key effectors in these signaling 
pathways. As shown in Figure 5a and b, although c-Met and EGFR associated signaling 
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pathways were activated in both Fut8+/+ and Fut8-/- mice 2 days post PH, the levels of 
phosphorylated c-Met (Tyr1234/5) and EGFR (Tyr1068) in Fut8-/- mice were obviously lower 
than that in Fut8+/+ mice. These results indicated that loss of Fut8 impaired EGFR and c-Met 
associated signaling during liver regeneration. 
To further corroborate the results above in vitro, we examined the downstream signaling 
cascades of EGF or HGF using the primary hepatocytes isolated from Fut8+/+ and Fut8-/- mice. 
Consistently, the treatments with EGF or HGF significantly increased the expression levels of 
phosphorylated ERK and AKT in the Fut8+/+ cells. However, these increases were greatly 
suppressed in the Fut8-/- cells (Figure 5d and e). The results above clearly demonstrated that the 
impaired regeneration in Fut8-/- livers was due, at least mainly, to the down-regulated EGFR- 
and c-Met-mediated signalings in hepatocytes. 
Figure 5. Intracellular signaling was suppressed in Fut8-/- mice upon either PH or EGF and HGF 
stimulation.  
8-week-old Fut8+/+ or Fut8-/- mice were surgically resected as described in “Methods”, and then the livers 
were harvested at 2 days. The liver homogenates were separated by 7% SDS-PAGE and blotted with 
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anti-EGFR and anti-phospho-EGFR antibodies (a), and anti-c-Met and anti-phospho-c-Met antibodies (b). 
The quantitative data were obtained from 3 mice in each group. *, P<0.05, **, P<0.01. The primary 
hepatocytes isolated from 8-week old Fut8+/+ and Fut8-/- mice were cultured in DMEM containing with 10% 
FBS for 12 h, and then cultured under DMEM containing with 0.1% FBS for 24 hours. After the starvation, 
these cells were stimulated with or without EGF at indicated concentrations for 5 min (c and d), or HGF at 
indicated concentrations for 10 min (e). The cell lysates were immunoblotted with anti-pEGFR and 
anti-EGFR, anti-pAKT and anti-AKT antibodies, anti-pERK and anti-ERK1 antibodies. The quantitative 
data were obtained from at least 3 independent experiments, *, P<0.05, **, P<0.0 1.  
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1.4 Discussion 
 
In the present study, we used a well-established regeneration model, to investigate the 
functions of Fut8 in liver regeneration, and found the following: i) The expression of Fut8 was 
markedly up-regulated during the regenerating process in the Fut8+/+ mice; ii) the liver 
regeneration was greatly inhibited in Fut8-/- mice compared to Fut8+/+ mice; iii) L-fucose 
supplementation could reverse the delayed regeneration in Fut8+/- mice; and, iv) the responses 
to growth factors such as EGF and HGF, were decreased in Fut8 deficient hepatocytes 
compared to wild-type hepatocytes. Overall, this study marks the first clear demonstration of 
the biological functions of Fut8 in the liver, suggesting that core fucosylation plays important 
roles in liver regenerating progression as shown in Fig.6.  
Figure 6. Proposed molecular mechanisms for the 
delayed liver regeneration in Fut8-/- mice. It is well 
known that the 70% partial hepatectomy could 
activate several cell proliferation associated signaling 
pathways including Ras/MAPK signaling, c-Met 
signaling, and Akt/mammalian targets of rapamycin 
(mTOR) signaling, which up-regulate the cell 
proliferation, and consequently lead to the restoration 
of liver. Loss of core fucosylation on growth factor 
receptors such as EGFR and c-Met may alter their 
conformation and impair their ligand binding, thereby 
inhibiting their downstream signalings, and ultimately 
suppressing the cell proliferation. Overall, a loss of Fut8 gene results in a decrease in liver regeneration.  
 
Liver regeneration after PH is a complicated process with the coordinated proliferation of all 
types of mature hepatic cells, which involves numerous molecules and signaling pathways (1, 2, 
6, 30). Among these, the EGFR-mediated signaling has been reported to be critical for liver 
regeneration (29). Lacking EGFR in hepatocytes increased the mouse mortality rate after PH, 
and delayed the hepatocyte proliferation (28), although little effect was observed on liver 
function. We have previously shown that core fucosylation on EGFR is required for its binding 
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to EGF and downstream signaling in embryonic fibroblast cells (11). Therefore, it is reasonable 
to consider that the delayed liver recovery of Fut8-/- mice could be attributed, at least mainly, to 
the loss of the core fucosylation on the EGFR protein (Figure 5c and d). In agreement with this 
hypothesis, we found here that knockout of Fut8 led to an inhibition of the EGFR-mediated 
signaling cascade both in vivo and in vitro. 
In addition to EGFR, c-Met has also been shown to play an irreplaceable role in liver 
regeneration. c-Met gene deficient or suppressed by shRNAs significantly inhibited the 
proliferation of hepatocytes after PH (28, 31, 32). In the present study, we found that knockout 
of Fut8 also attenuated the response to an HGF stimulus in primary hepatocytes (Figure 5e). 
Since c-Met is also a core fucosylated protein which had been confirmed by using human cell 
lines (data not shown), one possibility for this attenuated response is that like EGFR, the core 
fucosylation on c-Met may be necessary for its ligand binding and downstream signaling as 
well. Obviously, we could not exclude other possibilities. Recently, Tobias Speicher et al. 
reported that theβ1-integrin knockout or knockdown in mice inhibited liver regeneration by 
impairing the ligand-induced phosphorylation of EGFR and c-Met, as well as their downstream 
signalings (33). Considering also that α3β1 integrins were highly modified by Fut8 and loss of 
core fucosylation could result in the malfunction of β1-integrin (12), Fut8 may also affect the 
c-Met-mediated signaling in the liver regeneration by regulating the core fucosylation status of 
β1-integrin. Further investigation is required to confirm the hypotheses above. 
Increasing evidence indicated the importance of core fucosylation in protein-protein interaction, 
and we proposed here that Fut8 may affect the liver regeneration through modulating some 
associated receptor-ligand bindings. However, the mechanistic roles of Fut8 underlying the 
protein-protein interaction remain poorly understood. Recently, two research teams determined 
the complex structures of glycosylated FcγRIIIa and human core fucosylated or afucosylated 
Fc of IgG (34, 35). Interestingly, the crystal structures indicated that core fucose depletion 
increased the incidence of the active conformation of the Tyr-296 of Fc, and thereby 
accelerated the formation of the high-afﬁnity complex with its receptor. These findings clearly 
explained why the lack of a core fucose on IgG could greatly enhance antibody-dependent 
cell-mediated cytotoxicity as previously reported (36, 37). From a more general viewpoint, 
these studies provide direct evidence for the mechanistic roles of Fut8 in different biological 
processes, where the attachment of core fucose leads to an alteration of glycoprotein 
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conformation, which determines its protein dynamics coupled with the selection of 
protein-protein interactions and complex formation, and consequently affects the intracellular 
signaling pathways.  
The excellent results of liver transplantation have led to an increasing number of patients on 
the waiting list, while the number of liver donors remains stable (1, 38). Studies on potential 
hepatoprotective factors in liver injury may contribute to increasing the success ratio of liver 
transplantation. Here, we showed that liver regeneration is significantly inhibited in Fut8-/- 
mice. Moreover, L-fucose administration could partially complement the delayed liver recover 
in Fut8+/- mice. Clearly, there is a need to further elucidate the underlying mechanisms and 
confirm these observations of core fucosylation in human. However, the current study provides 
important evidence for the effect of L-fucose supplementation on liver regeneration and 
indicates the important role of Fut8 in liver regeneration. 
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Part 2 
 
 
 
 
 
 
Loss of α1,6-fucosyltransferase inhibits chemical induced 
hepatocellular carcinoma and tumorigenesis by down-regulating 
several cell signaling pathways 
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2.1 Introduction 
 
N-Linked glycosylation a common type of glycosidic bond. It has been shown to be important 
for folding, stability, and vast degree of biological functions of glycoproteins. These different 
effects on glycoproteins mainly result from the different N-linked glycan structures determined 
by various glycosyltransferases (9). Among these, α1,6-Fucosyltransferase (Fut8) is the only 
enzyme that catalyzes the transfer of a fucose from GDP-fucose to the innermost GlcNAc 
residue via α1,6-linkage in mammals. The resulting core fucosylated N-glycans are widely 
distributed in a variety of glycoproteins. It has been reported that core fucosylation is crucial 
for the ligand binding affinity of transforming growth factor (TGF)-β1 receptor (10), epidermal 
growth factor (EGF) receptor (11), and integrin α3β1 (12). Lacking the core fucose led to a 
marked reduction in ligand-binding ability and downstream signaling. Recently, we found that 
loss of core fucose on activin receptors also resulted in an enhancement of the formation of 
activin receptor complexes, which constitutively activated intracellular signaling (13). Those 
studies clearly suggest that Fut8 plays important roles in cell signal transduction. 
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality 
worldwide (39), and hepatocarcinogenesis is a complicated process associated with the 
accumulation of pathological changes during the initiation, promotion, and progression of the 
disease (40, 41). Identifying these changes may provide an avenue to develop a new generation 
of potential biomarkers, as well as therapeutic targets for HCC. It has been shown that altered 
expressions of growth factors such as EGF, TGF-α, TGF-β, and hepatocyte growth factor 
(HGF), as well as their receptors during the development of HCC, influence the survival of 
cancerous cells by suppressing apoptosis and regulating the cell cycle (41-44). Inhibitors 
targeting those receptors mediated signaling pathways have been successfully developed and 
used to improve the survival of patients with HCC (42). However, the therapeutic resistance 
also develops (45, 46). Recently, an inhibition of N-linked glycosylation had been reported as a 
novel therapeutic strategy for the treatment of gliomas and other malignant tumors (47). In 
contrast, the role of N-glycosylation in HCC is largely unknown. It has been shown that Fut8 
expression is up-regulated in both liver and serum during the process of hepatocarcinogenesis 
(14, 48), and the fucosylated alpha fetoprotein (AFP-L3) is a reliable marker that can be used 
to distinguish patients with HCC from those with chronic hepatitis and liver cirrhosis (49-51). 
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The HCC cases with high Fut8 expression is associated with the poor prognosis (52). These 
information prompted us to wonder what the pathological role of high Fut8 expression is in 
HCC progression and whether it could serve as a potential therapeutic target for liver cancer. 
To address these questions, here, the typical HCC model was established in the male wild-type 
(Fut8+/+), hetero (Fut8+/-) and knockout (Fut8-/-) mice by administration of diethylnitrosamine 
(DEN), which induces hepatocyte DNA damage, in conjunction with phenobarbital (PB), a 
well-known promoter of liver carcinogenesis (53-55). DEN and PB effectively induced the 
tumor formation in Fut8+/+ mice, while the tumor incidence was almost completely inhibited in 
Fut8-/- mice. The inhibitory effects of Fut8 were further confirmed by using human hepatoma 
cell line, HepG2. Knockout of Fut8 gene abolished tumorigenesis of the xenograft tumors 
formed by HepG2 cells in NOD/SCID mice. These results clearly demonstrate the importance 
of Fut8 in hepatocarcinogenesis and implicate Fut8 as a novel therapeutic approach for HCC 
treatment. 
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2.2 Materials and Methods 
 
2.2.1 Chemical HCC induction  
Six-week-old Fut8-/-, Fut8+/- and Fut8+/+ male mice were divided into two groups. The 
experimental group (n >10) received a single intraperitoneal injection of DEN (100 mg per kg, 
Sigma-Aldrich, St. Louis, MO, USA) and was provided 0.05% phenobarbital (Tokyo chemical, 
Japan) in water after 4 weeks, and the serum and livers were harvested after 40 weeks. 
Meanwhile, the control group received the same operation without agents. A blood chemical 
analysis was performed by using a Vet Scan VS2 automated analyzer (ABAXIS, Union City, 
CA, USA) with a mammalian liver profile multi-rotor.  
 
2.2.2 Liver histology and immunostaining 
The hepatic lobules were assessed based on 4 m hematoxylin and eosin-stained parafﬁn 
sections. Masson's trichrome staining was performed to show collagen fiber deposition. 
Immunostaining for P. squarrosa lectin (PhoSL), which specifically recognizes core fucose 
(56), was used to detect changes in core fucosylation during HCC induction. An in situ 
cell-death kit (Roche, Laval, Canada) was used for TUNEL staining with frozen sections (10 
m), according to the manufacturer’s instructions. Proliferative cells in the liver were detected 
through immunostaining with a monoclonal antibody recognizing Ki67 (Abcam, Cambridge, 
MA, USA), and the liver sinusoidal endothelial cells were labelled with anti-CD31 antibody 
(BD Bioscience, San Jose, CA, USA). 
 
2.2.3 Quantitative and semi-quantitative real-time PCR 
Total RNA from livers was extracted with TRI Reagent (MRC Inc., Cincinnati, OH, USA). 
Complementary DNA synthesis was carried out with PrimeScriptTM RT reagent Kit (TaKaRa, 
Japan) according to the manufacturer’s instructions. Quantitative real-time PCR reactions were 
performed with SYBR Premix Ex TaqTM Ⅱ kit (TaKaRa), and semi-quantitative PCR actions 
were carried out by using TaKaRa Ex Taq. Primers were listed in Table 1. Values of qPCR 
reactions were quantiﬁed using the comparative CT method, and normalized to GAPDH 
mRNA. 
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Table 1: Primer sequences used for qRT-PCR and RT-PCR 
 
Genes Direction Primers 
CYP 1a2 Forward: 
Reverse: 
5’-CCCGAGGAGAAGATTGTCAAC-3’ 
5’-CGATCCCTGCCAACCAC-3’ 
CYP 1b1 Forward: 
Reverse: 
5’- TGCCTGCCACTATTACGGA -3’ 
5’- GTCCCTCCCCACAACCTG -3’ 
CYP 2e1 Forward: 
Reverse: 
5’- CACTGGACATCAACTGCCC -3’ 
5’- ATGAGAATCAGGAGCCCATA -3’ 
CYP 3a11 Forward: 
Reverse: 
5’- GTCACAGACCCAGAGACGAT -3’ 
5’- TTTGCCTTCTGCCTCAAGTA -3’ 
Mgmt Forward: 
Reverse: 
5’- AGATGGAGCTGTCTGGCTGT -3’ 
5’- CCTCTGTGGGGTCAGTGTTT -3’ 
IL-6 Forward: 
Reverse: 
5’- TAGTCCTTCCTACCCCAATTTCC -3’ 
5’- TTGGTCCTTAGCCACTCCTTC -3’ 
TNF-α Forward: 
Reverse: 
5’- CCCTCACACTCAGATCATCTTCT -3’ 
5’- GCTACGACGTGGGCTACAG -3’ 
Fut8 Forward: 
Reverse: 
5’- CAGGGGATTGGCGTGAAAAAG -3’ 
5’- CGTGATGGAGTTGACAACCATAG -3’ 
Cyclin B1 Forward: 
Reverse: 
5’- CAGGGTCGTGAAGTGACTGG -3’ 
5’- GGCACACAACTGTTCTGCAT -3’ 
Cyclin D1 Forward: 
Reverse: 
5’- TCAAGTGTGACCCGGACTG -3’ 
5’- ACTTCCCCCTCCTCCTCAG -3’ 
Cyclin E2 Forward: 
Reverse: 
5’- ATTTGGCTTTGCTGAATGAAGT -3’ 
5’- TCCAGGTTGTTAACTTCAGTGTT -3’ 
GAPDH Forward: 
Reverse: 
5’- AAATGGTGAAGGTCGGTGTG -3’ 
5’- TGAAGGGGTCGTTGATGG -3’ 
 
2.2.4 Cell culture and transfection 
Human hepatoma HepG2 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
with 10% (v/v) fetal bovine serum (FBS), 100 IU/mL penicillin, and 100 g/ml streptomycin. 
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The Fut8 knockout CompoZr Zinc Finger Nuclease (ZFN) plasmids (Sigma) and GFP control 
plasmid were transfected into the cell lines via a TransIT-2020 Transfection Kit (Mirus Bio, 
Madison, WI, USA), and stable cell lines were selected via mushroom Pholiota Squarrosa 
lectin (PhoSL) staining by BD FACSAria II. The cells were incubated for 6 h at 37 ˚C in a 
humidified atmosphere with 95% air and 5% CO2, allowing for cell attachment to the plate. 
The medium was then changed, which involved replacement by 0.1% FBS contained DMEM 
with or without EGF or HGF for stimulation at indicated times.  
 
2.2.5 Genomic PCR to detect Fut8  
The removal of the Fut8 gene in HepG2 cell was confirmed by PCR, ZFN Primer F; 5'- 
TGTCAGGTGAAGTGAAGGACA -3' and Primer R; 5'- 
ATCAGATTCTTACCCAATAACTGG-3'. 
 
2.2.6 Western blotting and lectin blot analyses 
Shown in Chapter 1.2.5 
 
2.2.7 Immunoprecipitation and cell surface biotinylation 
The cell lysate (500 g total protein) was incubated with 10 l FG streptavidin beads 
(Tamagawa Seiki, Japan) containing 2 g PhoSL for 2 hours at 4 ˚C, followed by washing 3 
times with lysis buffer. The immunoprecipitate was dissolved in a 20l SDS-PAGE sample 
solution. For cell surface biotinylation, cells were incubated with 0.2 mg/ml 
sulfosuccinimidobiotin (Thermo Scientific) on ice for 2 hours, and then were solubilized in 
lysis buffer. The biotinylated proteins were precipitated with 50 l streptavidin agarose beads 
(Millipore, 2h, 4 ˚C), and visualized by Western blot analysis.  
 
2.2.8 Established tumors originating from HepG2 cells 
Six-week-old male NOD/SCID mice were purchased from Charles River Laboratories, INC. 
The mice were inoculated subcutaneously with 5×106 HepG2 WT and Fut8 KO cells into the 
dorsal flanks, and the tumor tissues were harvested after 4 weeks. 
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2.3 Results 
 
2.3.1 Loss of the Fut8 gene inhibited DEN/PB-induced tumor formation 
To assess the effects of Fut8 on the development of HCC, 6-week-old Fut8+/+, Fut8+/- and 
Fut8-/- male mice were exposed to the carcinogen DEN and liver tumor promoter PB. The 
absence of Fut8 significantly decreased HCC formation in response to DEN and PB when 
compared with Fut8+/+ mice. Interestingly, the Fut8+/- mice also showed a lower incidence of 
tumors, although there was no significant difference compared with the Fut8+/+ mice (Figure 
1b). Morphologic examination revealed that livers of Fut8+/+ model mice showed multiple 
large, vascularized nodules at the 40th week, while this phenomenon was rarely observed in 
Fut8-/- mice (Figure 1a). Consistently, Masson's trichrome staining showed much more collagen 
deposition in DEN/PB-treated Fut8+/+ group as compared with the control and Fut8-/- mice. 
Meanwhile, in agreement with the tumor incidence, a significant increase in liver/body weight 
ratios after DEN/PB treatment was observed for the Fut8+/+ model mice, but not the Fut8-/- 
mice (Figure 1c). The ratio for Fut8+/- mice showed a decreased tendency when compared with 
that of Fut8+/+, albeit not as compared with that of Fut8-/- mice (Figure 1c). Furthermore, the 
serum biochemical analysis for alanine aminotransferase (ALT), alkaline phosphatase (ALP), 
and bile acids (BA), showed that DEN and PB induction destroyed liver functions of both 
Fut8+/+ mice and Fut8+/- mice, but not the Fut8-/- mice (Figure 1d). These results strongly 
suggest that the expression of Fut8 plays an important role in pathological functions. 
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Figure 1. Hepatocarcinogenesis was inhibited in Fut8−/− mice.  
(a) The DEN/PB treated Fut8+/+ mice showed multiple large, vascularized nodules at the 40th week compared 
with the control group, while this phenomenon was rarely observed in Fut8−/− mice (upper panel, bar=1cm). 
Sections (4 μm thick) from formalin-fixed, paraffin-embedded liver lobe of control and DEN/PB-treated 
Fut8+/+ and Fut8−/− male mice were used for histologic analysis by H&E (middle panel, bar=1 mm) and 
Masson's trichrome staining (lower panel, bar=1 mm). (b) Tumor incidence in different groups after 
DEN/PB-treatment (n>10). (c) Relative liver weight in different groups after 40 weeks. *, P<0.05, compared 
to Fut8+/+ control mice. (d) The expression levels of ALT, ALP and BA in the serum were analyzed by using 
a Vet Scan VS2 automated analyzer as described in “Materials and Methods”. *, P<0.05, compared to Fut8+/+ 
control mice. 
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2.3.2 Chemical treatment induced the expression of Fut8  
The expression of Fut8 and its products are elevated in both liver and serum during the process 
of human hepatocarcinogenesis (14). The increase in core fucosylated N-glycans has been also 
observed in DEN-induced HCC rat models (57).  To confirm whether it is also the case in 
mice, here, we tested the activities of Fut8 in Fut8+/+ mice. As shown in Figure 2a and 2b, the 
Fut8 enzyme activities were remarkably enhanced in DEN/PB treatment models as compared 
with the control. The mRNA expression of Fut8 also showed a dual phase elevation during the 
process of hepatocarcinogenesis, which reached a plateau after 36 weeks (Figure 2c). The 
underlying molecular mechanism for the dual phase reaction is unclear. Immunostaining 
analysis using PhoSL which specifically recognized the core fucose showed that the increases 
in Fut8 expression and enzyme activities were accompanied by the enhancement of its 
enzymatic products (Figure 2d). And these core fucose did not localize in the liver sinusoidal 
endothelial cells, which were stained by anti-CD31 antibody (Figure 2e). Thus, we believed 
that it might mainly localize in hepatocytes. Taken together, these results indicate that Fut8 is 
expressed at lower level under physiological conditions in the liver, which could be 
up-regulated after stimulus, and thereby affect the subsequent pathological processes. 
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Figure 2. The expression of Fut8 and its products were induced after DEN/PB treatment. 
(a) The relative activities of Fut8, as determined by HPLC, as described in “Chapter 1.2.6”. The red arrows 
show the products of Fut8 after the reaction. (b) The quantitative assay for enzyme activities in Fut8+/+ mice 
with or without the DEN/PB treatment. *, P<0.05, compared to the control group without the treatment. (c) 
The expression of Fut8 mRNA showed a dual phase increase during the DEN/PB induced tumorigenesis. *, 
P<0.05, compared to the control group without the treatment (n=3-4). (d) PhoSL immunostaining for 
paraffin-embedded sections (4 μm thick) of liver tissues. The immunostaining for Fut8−/− mice was used as a 
negative control. (e) The frozen liver sections (10 μm thick) of Fut8+/+ mice treated with DEN/PB were 
co-immunostained with PhosSL (green) and anti-CD31 antibody (red), which is a marker for the sinusoidal 
endothelial cells. The nuclei were labeled by TO-PRO-3 iodide (blue). 
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2.3.3 Comparison of the acute phase responses for DEN injection between Fut8+/+ and 
Fut8-/- mice 
DEN itself does not exert carcinogenicity. It needs to be bioactivated by cytochrome P450 
(CYP) enzymes in the liver (58). For instance, CYP2e1-deficient mice showed lower tumor 
incidence and multiplicity compared with wild-type mice for DEN-induced 
hepatocarcinogenesis (59). After activated, DEN resulted in DNA-adducts which forming 
through an alkylation mechanism, and the alkylated DNA-adducts can be removed by a DNA 
repair gene O6-methylguanine-DNA methyltransferase (Mgmt) (60). To check the early effects 
of DEN in Fut8+/+ and Fut8-/- mice, semi-quantitative or quantitative PCR analysis of mRNAs 
encoding the CYP enzyme (Figure 3a) and Mgmt (Figure 3b) genes was performed at 2 h after 
DEN injection. There was no significant difference in the transcriptional levels of either CYP 
genes or DNA repair gene between Fut8+/+ and Fut8-/- mice. DEN-induced tumor formation 
was further associated with substantial and marked induction of proinflammatory chemokines 
within the livers of mice. After DEN injection, IL-6 and TNF-α were induced, resulting in the 
cytokine-driven compensatory proliferation (61). Quantitative PCR analysis of livers after 
DEN injection revealed an increase in IL-6 expression in both Fut8+/+ and Fut8-/- mice, 
although the expression level in Fut8+/+ control mice was lower than that in Fut8-/- control ones. 
The mRNA expression levels of TNFα were also induced after DEN injection, but there was no 
significant difference between the Fut8+/+ and Fut8-/- mice (Figure 3c). Moreover, TUNEL 
assay for the livers showed the similar results (Figure 3d). These data demonstrate that the 
expression of Fut8 may not affect the acute phase response to DEN. 
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Figure 3. No big difference in the acute response was observed between the Fut8+/+ and Fut8-/- mice 
after DEN injection.  
(a) Semi-quantitative PCR analysis of cytochrome P450 enzymes after DEN injection (n=3-5). (b) 
Quantitative PCR analysis of the DNA repairing gene (Mgmt) after DEN injection (n=3-5). (c) The mRNA 
expression levels of IL-6 and TNFα in the liver were detected by quantitative PCR after DEN injection at 2 
hours (n=3-5). (d) TUNEL analysis was performed using the frozen liver tissues (10μm thick, green), the 
nuclei were labeled by TO-PRO-3 iodide (blue). The quantitative data were obtained from at least 3 mice. **, 
P<0.01, *, P<0.05, compared to the control mice. 
 
2.3.4 Cell proliferation induced by DEN/PB treatment is inhibited in the Fut8-/- mice 
Cell proliferation plays important roles in HCC process (41, 62). In order to find the possible 
mechanisms for the differences in tumorigenesis described above, we carried out Ki67 
immunostaining for the frozen liver tissues of Fut8+/+ and Fut8-/- mice. Without DEN/PB 
treatment, both Fut8+/+ and Fut8-/- mice showed few positive cells in the liver, and there was no 
significant difference between the control groups. After chemical induction, the Fut8+/+ mice 
showed a significant increase by more than ~6.5-fold in positive immunostaining as compared 
with the untreated control. However, only a 2-fold increase was observed in Fut8-/- mice 
(Figure 4a and 4b). To further confirm the difference in cell proliferation after DEN/PB 
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induction between Fut8+/+ and Fut8-/- mice, qPCR analysis of mRNAs encoded by cell cycle 
control genes was performed. The expression levels of cyclin mRNAs, including Cyclin B1, 
Cyclin D1 and Cyclin E2, were up-regulated in Fut8+/+ mice after DEN/PB treatment, and the 
elevations in gene expression were attenuated by the ablation of Fut8 (Figure 4c). These results 
indicate that Fut8 may influence the progress of DEN/PB induced HCC by affecting the cell 
proliferation. 
Figure 4. Knockout of Fut8 led to a suppression of cell proliferation.  
(a) Immunostaining for liver tissues of Fut8+/+ and Fut8−/− mice using anti-Ki67 antibody (40×field). The 
positive cells of the immunostaining were labeled with the green spots (left panel), and the nuclei were 
labeled by TO-PRO-3 iodide (red spots, middle panel). (b) The quantitative data were obtained from at least 
3 mice in each group (10×field). **, P<0.01, compared to the Fut8+/+ mice. (c) qPCR Analysis of cell cycle 
control genes-encoded mRNAs. **, P<0.01, *, P<0.05, compared to the control mice. n=3-4.  
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2.3.5 Cell proliferation and tumor growth were inhibited in Fut8 gene knockout HepG2 
cell line 
To further confirm the observation in vitro, we established the stable Fut8 KO HepG2 cell line 
by ZFN technique. The knockout efficiency was verified not only by the lectin blot with 
Aleuria aurantia lectin (AAL), which recognizes the core fucosylation on N-glycans (upper 
panel), but also by the genomic DNA PCR (lower panel) (Figure 5a). Fut8 knockout in HepG2 
cells led to a significant inhibition of cell growth (Figure 5b), indicating that the cell 
proliferation induced by DEN/PB could be suppressed by the loss of Fut8. To further evaluate 
the impact of Fut8 on tumor growth in vivo, a xenograft tumor model was established in 
nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice. The WT and Fut8 
KO HepG2 cells were implanted subcutaneously into NOD/SCID mice to allow tumor 
formation. At four weeks post-injection, in contrast to the clear tumors in the WT group, the 
xenograft tumor formation in Fut8 KO group was almost completely abolished (Figure 5c), 
which indicates that Fut8 gene knockout suppresses tumorigenesis in vivo. 
Figure 5. Knockout Fut8 gene in 
HepG2 cells suppressed cell 
proliferation in vitro and xenograft 
tumor growth in vivo.  
(a) The Fut8 gene in HepG2 cells was 
knocked out using a ZFN technique, as 
described in the “Materials and 
Methods” section. As shown in the 
figure, AAL (Aleuria aurantia lectin) 
staining, which specifically recognized 
core fucose, disappeared in the Fut8 knockout cells (upper panel). And this result also confirmed by the 
genomic DNA PCR (lower panel). (b) The cell proliferations of the Fut8 KO HepG2 cells were slower than 
those of control cells. The relative cell numbers are shown as the ratios of cell numbers after cultured versus 
numbers of the 1st day in the same area. Each set of the reported data was acquired from at least three 
independent experiments (n > 8). (c) Knockout of Fut8 remarkably reduced the volumes and weights of the 
tumor. The tumors formed by HepG2 WT or HepG2 Fut8 KO stable cells in NOD/SCID mice were 
measured at 4 weeks after injection. ***, P<0.001, compared to the control group (n=6).  
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2.3.6 The responses to EGF and HGF stimulus were attenuated in the Fut8 knockout cells 
It has been reported that EGF and HGF-mediated signaling pathways are important for cell 
proliferation (41, 42). There is also evidence that core fucosylation is capable of regulating the 
functions of certain receptors (10, 11). So, we are wondering whether core fucosylation could 
affect the responses to EGF or HGF stimulation in HepG2 and its Fut8 KO cell line. To address 
this question, first, we confirmed that both EGFR and c-Met were modified by Fut8 in HepG2 
cells by immunoprecipiation analysis with PhoSL (Figure 6a and 6b, upper panels). Also, we 
found that there was no difference in the expression levels of EGFR and c-Met between Fut8 
KO HepG2 cells and the parent cells, either on cell surface or in total cell lysates (Figure 6a 
and 6b, middle panels). The treatments with EGF or HGF significantly increased the 
phosphorylation levels of EGFR, c-Met, ERK and AKT in wild-type cells. However, these 
increases were greatly suppressed in Fut8 KO HepG2 cells (Figure 6c and 6d). Considering 
also our previously reported that core fucosylation was required for the binding of the EGF to 
EGFR (11), it is reasonable to conclude that lacking the core fucosylation on both receptors 
may decrease their biological functions in vitro or in vivo. 
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Figure 6. The phospho-AKT and -ERK levels upon EGF and HGF stimulation were suppressed in 
Fut8 KO HepG2 cells.  
(a) Comparison of the core fucosylation of EGFR and its expression levels on the cell surface between 
control and Fut8 KO HepG2 cells. (b) Comparison of the core fucosylation of c-Met and its expression 
levels on the cell surface between control and Fut8 KO HepG2 cells. (c) Cell lysates obtained from the cells 
with or without EGF-treatment were immunoblotted with anti-pAKT and AKT (upper panel), pERK and 
ERK1 antibodies (lower panel). (d) The control and Fut8-KO HepG2 cells were stimulated by HGF, and 
their cell lysates were collected and used for immunoblotting as described above. 
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2.4 Discussion 
 
In the present study, we used a well-established HCC model, DEN/PB 
induced-hepatocarcinogenesis, to investigate the functions of Fut8 in HCC, and found the 
following: i) Tumor incidence was greatly inhibited in Fut8-/- mice compared to Fut8+/+ mice; ii) 
the expression of Fut8 was markedly up-regulated during the DEN/PB induced- 
hepatocarcinogenesis of Fut8+/+ mice; iii) Fut8 knockout abolished the HepG2 xenograft tumor 
formation in NOD/SCID mice; iv) the responses to growth factors such as EGF and HGF, were 
decreased in Fut8 deficient cells compared to wild-type cells. Overall, this study marks the first 
clear demonstration of the biological functions of Fut8 in HCC, suggesting that the levels of 
core fucosylation are not only serve as biomarkers for HCC, but also function as important 
signaling modulators during the progression of hepatocarcinogenesis, which provides insight 
into the development of promising glyco-therapeutic methods for HCC. 
As far as can be ascertained, inflammation-induced mutagenesis in the normal cells is regarded 
as the initiation in HCC, and there is an evidence that DNA damage can lead to inflammation 
and thereby promote tumorigenesis (63). One of the best examples is the model of HCC that 
induced by the carcinogen DEN, in which DNA damage results in an inflammatory reaction 
that promotes tumor development (61, 64). In our study, the acute responses to DEN were also 
detected. However, no significant difference was observed in the expression of cytokines and 
dead cells induced by DEN between the Fut8+/+ and Fut8-/- mice (Figure 3c and d). Meanwhile, 
the alterations of body weight showed the similar tendency within 2 weeks after DEN injection 
in Fut8+/+ and Fut8-/- mice (data not shown). These results clearly indicated that Fut8 did not 
influence the initial step of hepatocarcinogenesis.  
The increased cell proliferation is essential for initial tumor growth. It is often accompanied by 
the enhanced expression of some growth factors, leading to the activation of 
RAS/mitogen-activated protein kinase kinase (MAPKK) signaling, c-Met signaling, or 
Akt/mammalian targets of rapamycin (mTOR) signaling and consequently inﬂuencing the 
survival of cancerous cells by suppressing apoptosis and regulating the cell cycle (41, 42). In 
fact, Fut8, which control the core fucosylation status on cell surface molecules globally, plays 
important roles in cell signal transduction. We previously reported that core fucosylation was 
required for the binding of EGF to its receptor and for the regulation of EGFR-mediated 
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intracellular signaling in embryonic fibroblast cells(11) . Considering also the reduced response 
to EGF stimulation in Fut8 KO HepG2 cells, it is reasonable to conclude that the inhibition of 
tumor formation in Fut8-/- mice is at least partially mediated by the attenuated EGFR-mediated 
signaling. On the other hand, hepatocyte growth factor and its receptor also play a critical role 
in HCC, and the HGF/c-Met pathway serves as a promising target for HCC treatment (42, 44, 
62). Our results showed that lacking Fut8 gene also attenuated the response to an HGF 
stimulus in HepG2 cells (Figure 6d). So, the reduced HGF/c-Met mediated signaling could be 
another reason for the suppressed tumorigenesis in Fut8-/- mice. Nonetheless, we still cannot 
exclude the possibility that Fut8 may influence the functions of some other glycoproteins, since 
core fucose widely exists on cell surface. Overall, it could be postulated that a loss of the Fut8 
gene may affect the biological functions of some target membrane proteins and their 
subsequent downstream signaling, thereby inhibiting the hepatocarcinogenesis (Figure 7). 
Despite the well-established link between the core fucosylation and the function of 
glycoproteins like EGFR (11), TGF-β1 receptor (10), etc., the underlying molecular 
mechanisms still remain poorly understood. Recently, the complex structures of glycosylated 
FcγRIIIa and human core fucosylated or afucosylated Fc of IgG have been determined, which 
indicated that core fucose depletion increased the incidence of the active conformation of the 
Tyr-296 of Fc, and thereby accelerated the formation of the high-afﬁnity complex with its 
receptor (34, 35). These studies clearly explained why the lack of a core fucose on IgG could 
greatly enhance antibody dependent cellular cytotoxicity (36, 37). From a more general 
viewpoint, these studies provide evidence that core fucose on a glycoprotein may affect its 
conformation, complex formation and protein dynamics coupled with the selection of 
protein-protein interactions, then positively or negatively regulating intracellular signaling 
pathways. So, the mechanisms for the aberration of EGF and HGF signaling in Fut8-/- mice, 
could be that loss of core fucosylation affects the steric structure of EGFR and c-Met, which 
then impairs dimeric formation and the complex formation between receptor and ligand. Taken 
together, our study thereby emphasizes that Fut8 is not only an important diagnostic marker, 
but also plays pathological roles in the hepatocarcinogenesis, which sheds light on discovering 
a novel therapy for HCC. 
In the past few years, small molecule receptor tyrosine kinase inhibitors and receptor-specific 
monoclonal antibodies, which targeting receptor-mediated multiple strategies, have been 
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successfully used for HCC patients (65). However, other receptors mediated compensatory 
resistance also developed. For instance, c-Met has been reportedly implicated in acquired 
resistance to gefitinib or erlotinib, which have been proved to be useful in series of anti-cancer 
therapies by inhibiting EGFR kinase (66). Since Fut8 has the advantage of affecting multiple 
cell signal pathways mediated by series of receptors, inhibition of Fut8 could effectively block 
the DEN/PB induced HCC, as shown in the current study (Figure 1a). In addition, abnormal 
expression of Fut8 was also observed with diverse carcinomas including ovarian (15), lung (16) 
and colorectal cancers (17), and recent study showed that microRNA-198 which targets Fut8 
could suppress the proliferation and invasion of colorectal cancer (67). Considering also our 
data here that loss of Fut8 has no influence on the normal functions of the liver, we believe that 
Fut8 might serve as an effective therapeutic target for HCC, and other cancers if possibly. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Proposed molecular mechanism for the inhibition of HCC in Fut8 knockout mice.  
It is well known that the cytokines such as EGF and HGF could up-regulate the cell proliferation by 
activating several associated signaling pathways, including Ras/mitogen-activated protein kinase kinase 
(MAPKK) signaling, c-Met signaling and Akt/mammalian targets of rapamycin (mTOR) signaling, and 
finally leads to HCC. Core fucosylation on growth factor receptors such as EGFR and c-Met plays very 
important roles in the interaction between ligands and receptors. Loss of core fucosylation may alter their 
interactions, and then down-regulate their intracellular signaling and inhibit cell proliferation (dash lines). 
Overall, loss of Fut8 gene results in a decrease in hepatocarcinogenesis.  
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